» Articles » PMID: 12933819

Adenosine A2A-dopamine D2 Receptor-receptor Heteromerization: Qualitative and Quantitative Assessment by Fluorescence and Bioluminescence Energy Transfer

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Aug 23
PMID 12933819
Citations 169
Authors
Affiliations
Soon will be listed here.
Abstract

There is evidence for strong functional antagonistic interactions between adenosine A2A receptors (A2ARs) and dopamine D2 receptors (D2Rs). Although a close physical interaction between both receptors has recently been shown using co-immunoprecipitation and co-localization assays, the existence of a A2AR-D2R protein-protein interaction still had to be demonstrated in intact living cells. In the present work, fluorescence resonance energy transfer (FRET) and bioluminescence resonance energy transfer (BRET) techniques were used to confirm the occurrence of A2AR-D2R interactions in co-transfected cells. The degree of A2AR-D2R heteromerization, measured by BRET, did not vary after receptor activation with selective agonists, alone or in combination. BRET competition experiments were performed using a chimeric D2R-D1R in which helices 5 and 6, the third intracellular loop (I3), and the third extracellular loop (E3) of the D2R were replaced by those of the dopamine D1 receptor (D1R). Although the wild type D2R was able to decrease the BRET signal, the chimera failed to achieve any effect. This suggests that the helix 5-I3-helix 6-E3 portion of D2R holds the site(s) for interaction with A2AR. Modeling of A2AR and D2R using a modified rhodopsin template followed by molecular dynamics and docking simulations gave essentially two different possible modes of interaction between D2R and A2AR. In the most probable one, helix 5 and/or helix 6 and the N-terminal portion of I3 from D2R approached helix 4 and the C-terminal portion of the C-tail from the A2AR, respectively.

Citing Articles

Adenosine A and dopamine D receptor interaction controls fatigue resistance.

Alves A, Santos N, Santos A, da Panatta G, Speck A, Cunha R Front Pharmacol. 2024; 15:1390187.

PMID: 38860172 PMC: 11163034. DOI: 10.3389/fphar.2024.1390187.


Targeting the adenosine A receptor for neuroprotection and cognitive improvement in traumatic brain injury and Parkinson's disease.

Zhao Y, Zhou Y, Chen J Chin J Traumatol. 2023; 27(3):125-133.

PMID: 37679245 PMC: 11138351. DOI: 10.1016/j.cjtee.2023.08.003.


Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases.

Liu H, Ma H, Zeng X, Wu C, Acharya S, Sudan S Int J Mol Sci. 2023; 24(12).

PMID: 37373182 PMC: 10298151. DOI: 10.3390/ijms241210031.


Adenosine A Receptor Activation Regulates Niemann-Pick C1 Expression and Localization in Macrophages.

Skopal A, Ujlaki G, Gerencser A, Banko C, Bacso Z, Ciruela F Curr Issues Mol Biol. 2023; 45(6):4948-4969.

PMID: 37367064 PMC: 10297445. DOI: 10.3390/cimb45060315.


Screening of Membrane Protein Production by Comparison of Transient Expression in Insect and Mammalian Cells.

Kaipa J, Krasnoselska G, Owens R, van den Heuvel J Biomolecules. 2023; 13(5).

PMID: 37238687 PMC: 10216445. DOI: 10.3390/biom13050817.